As the software selloff deepens, ServiceNow’s CEO is buying the dip and joining others at his company in ending automated stock-selling plans.
Source: https://www.marketwatch.com/story/servicenow-ceo-looks-to-ca…
Artificial intelligence (AI) promises transformative productivity gains, but it also amplifies cybersecurity risks on an unprecedented scale.
Eli Lilly is at the forefront of the GLP-1 weight loss drug market. The company’s leading position is already being tested by Novo Nordisk’s GLP-1 weight loss pill.
On Tuesday, Cathie Wood bought shares of AMD, BYD, and WeRide. AMD was the only one of the three to move higher, but the stock has slipped 13% since peaking in October.
